References
Al Wahbi A (2018) Autoamputation of diabetic toe with dry gangrene: a myth or a fact? Diabetes Metab Syndr Obes 11:255–264. https://doi.org/10.2147/DMSO.S164199
Kumar B, Saraswat A, Kaur I (2002) Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. Clin Exp Dermatol 27(1):8–13. https://doi.org/10.1046/j.0307-6938.2001.00947.x
Vassallo C, Passamonti F, Merante S, Ardigo M, Nolli G, Mangiacavalli S, Borroni G (2001) Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia. Clin Exp Dermatol 26(2):141–148. https://doi.org/10.1046/j.1365-2230.2001.00782.x
Best PJ, Daoud MS, Pittelkow MR, Petitt RM (1998) Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med 128(1):29–32. https://doi.org/10.7326/0003-4819-128-1-199801010-00005
Chaine B, Neonato MG, Girot R, Aractingi S (2001) Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. Arch Dermatol 137(4):467–470
Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB (2008) Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 148(12):939–955. https://doi.org/10.7326/0003-4819-148-12-200806170-00221
Leo E, Kramer A, Hochhaus A, Krasniqi F, Hehlmann R, Ho AD (2002) Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy. Ann Hematol 81(8):467–469. https://doi.org/10.1007/s00277-002-0505-0
Yasuda N, Ohmori S, Usui T (2000) Hydroxyurea-induced gangrene of the toes in a patient with chronic myelogenous leukemia. Am J Hematol 63(2):103–104. https://doi.org/10.1002/(sici)1096-8652(200002)63:2%3C103::aid-ajh11%3E3.0.co;2-n
Montefusco E, Alimena G, Gastaldi R, Carlesimo OA, Valesini G, Mandelli F (1986) Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia. Tumori 72(3):317–321. https://doi.org/10.1177/030089168607200314
Monfort JB, Senet P (2020) Leg Ulcers in Sickle-Cell Disease: treatment update. Adv Wound Care (New Rochelle) 9(6):348–356. https://doi.org/10.1089/wound.2018.0918
Minniti CP, Kato GJ (2016) Critical reviews: how we treat sickle cell patients with leg ulcers. Am J Hematol 91(1):22–30. https://doi.org/10.1002/ajh.24134
Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S (2015) Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2015(6):CD004123. https://doi.org/10.1002/14651858.CD004123.pub4
Funding
This study was not funded.
Author information
Authors and Affiliations
Contributions
Each author was involved in the writing of the manuscript. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to participate
Written informed consent was obtained from the patient for the publication of this case report and accompanying images.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bhangu, G., Uminski, K., Roessner, C. et al. Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report. Ann Hematol (2024). https://doi.org/10.1007/s00277-024-05732-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00277-024-05732-w